YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike who wrote (1044)	1/16/2003 4:59:02 PM
From: Sergio H	Read Replies (1) of 23958

Mike, I'm having a difficult time setting a price target on MDCO using fundamentals. Fundamentally, no debt and strong revenue growth is very attractive, but the co. cpntinues to be in the red with no sign of green. Unless they have an unlikely positive surprise when earnings are announced in Feb., a likely event will be a sell-off on profit taking The 20 price target that Ken set looks reasonable, but a stab at 22 area, where the stock last topped off is doable as long as MDCO continues to announce potential catalysts. I haven't been able to dig up anything on the status of their potential second product, clevidipine. Are you familiar with what's going on with this drug?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next